摘要
新型冠状病毒肺炎(corona virus disease 2019, COVID-19)是一种传染性极强的呼吸道疾病,可通过人类呼出的气体感染,对全球公共卫生产生巨大影响。COVID-19的早期诊断和阳性病例的隔离已被证明是遏制感染蔓延的基础。尽管基于聚合酶链反应(polymerase chain reaction, PCR)的方法仍然是诊断COVID-19的金标准,但对快速和大规模诊断的迫切需求促使了替代诊断方法的发展。挥发性有机化合物(volatile organic compounds, VOC)已经显示出作为各种疾病的生物标志物的巨大潜力,VOC谱可以在感染过程中被病原体本身、宿主-病原体相互作用或宿主免疫反应改变。基于呼出气VOC的检测技术提供了一种简单、快速、无创、即时的诊断方法,可望用于大规模筛查,并最终优化COVID-19的防控策略,是一种很有前途的替代方法。本文综述了VOC检测COVID-19的作用原理、研究现状、存在的不足以及展望。
Coronavirus disease 2019(COVID-19) is a highly contagious respiratory disease that can be transmitted through human exhaled breath and has a huge impact on global public health. Early diagnosis of COVID-19 and isolation of positive cases have proven to be fundamental to containing the spread of infection. While polymerase chain reaction(PCR)-based methods remain the gold standard for diagnosing COVID-19, the urgent need for rapid and large-scale diagnosis has promote to the development of alternative diagnosis methods. Volatile organic compounds(VOCs) have shown great potential as biomarkers for a variety of diseases. VOC profiles can be altered by the pathogen itself, host-pathogen interactions, or host immune responses during infection. Exhaled VOC-based detection technology provides a simple, rapid, non-invasive, and immediate diagnostic method that is expected to be a promising alternative for large-scale screening and ultimately optimizing COVID-19 prevention and control strategies. In here, we have reviewed the principle of VOC detection for COVID-19, the current research status, the existing shortcomings and the prospects.
作者
吴超玲
陈远荣
付亮
邓国防
袁小亮
WU Chao-ling;CHEN Yuan-rong;FU Liang;DENG Guo-fang;YUAN Xiao-liang(The First Clinical Medical College of Gannan Medical University,Ganzhou,Jiangxi 341000,China;The Second Department of Pulmonary Diseases,The Third People's Hospital of Shenzhen Affiliated to South University of Science and Technology,Shenzhen,Guangdong 518112,China;The Department of Pneumology,The First Affiliated Hospital of Gannan Medical University,Ganzhou,Jiangxi 341000,China)
出处
《中国热带医学》
CAS
2022年第7期685-690,共6页
China Tropical Medicine
基金
国家自然科学基金项目(No.82070016)
江西省自然科学基金(No.20202BABL206116)
深圳市第三人民医院院内项目(No.G2022003)
深圳市第三人民医院院内项目(No.FSSYKF-2020001)。